Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 5

Dita Gratzinger1, Elaine S Jaffe2, Amy Chadburn3

  • 1From the Stanford University School of Medicine, Stanford, CA.

Insights

Primary immunodeficiencies can lead to various lymphoproliferations, including autoimmune lymphoproliferative syndrome (ALPS) and common variable immunodeficiency (CVID). Recognizing specific T-cell expansions is crucial to avoid misdiagnosing these conditions as lymphoma.

Area of Science:

  • Hematopathology
  • Immunology
  • Genetics

Background:

  • Primary immunodeficiencies (PIDs) encompass a range of conditions affecting the immune system.
  • Lymphoproliferative disorders can arise in the context of PIDs, necessitating careful evaluation.
  • The 2015 Society for Hematopathology/European Association for Haematopathology workshop focused on PIDs and related lymphoproliferations.

Purpose of the Study:

  • To review and categorize primary immunodeficiencies and their associated lymphoproliferative disorders.
  • To highlight the spectrum of lymphoproliferations seen in PIDs.
  • To provide guidance on differentiating PID-related lymphoproliferations from other conditions.

Main Methods:

  • Classification of PIDs into categories: immune dysregulation, DNA repair defects, low immunoglobulins, and combined immunodeficiencies.
  • Review of clinical and pathological features of lymphoproliferations in PIDs.
  • Analysis of T-cell subset expansions and their diagnostic implications.

Main Results:

  • Autoimmune lymphoproliferative syndrome (ALPS) exemplifies immune dysregulation, characterized by T-cell signaling/apoptosis defects and predisposition to hemophagocytic lymphohistiocytosis.
  • DNA repair defects are directly linked to an increased risk of malignancy.
  • Low immunoglobulin immunodeficiencies, such as common variable immunodeficiency (CVID), involve T-cell repertoire abnormalities contributing to autoimmunity and B-cell lymphoproliferations.
  • The full spectrum of B-cell lymphoproliferative disorders is observed in patients with PIDs.

Conclusions:

  • Lymphoproliferations in PIDs share similarities with those in other immunodeficiency settings.
  • Monomorphic B- and T-cell lymphoproliferative disorders are frequently observed in PIDs with DNA repair defects.
  • Distinctive T-cell subset expansions in ALPS, CVID, and related conditions can mimic lymphoma.
  • Accurate identification of double-negative T-cell or cytotoxic T-cell expansions is essential to prevent overdiagnosis of lymphoma.
Abstract